Terms: = Lymphoma AND PRKAR1A, DKFZp779L0468, 5573, ENSG00000108946, PRKAR1, P10644, CNC1, PKR1, MGC17251, PPNAD1, TSE1, CNC, CAR AND Diagnosis
118 results:
1. [Clinical Analysis of Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia in Children].
Li TD; Hu SY; Zhai Z; Chen GH; Lu J; He HL; Xiao PF; Li J; Wang Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Feb; 32(1):78-84. PubMed ID: 38387903
[TBL] [Abstract] [Full Text] [Related]
2. [Clinical features and prognostic analysis of testicular relapse in pediatric acute lymphoblastic leukemia].
Wang N; Gao YY; Qi BQ; Ruan M; Lyu H; Zhang XY; Zhang RR; Liu TF; Chen YM; Zou Y; Guo Y; Yang WY; Zhang L; Zhu XF; Chen XJ
Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):262-267. PubMed ID: 38378289
[No Abstract] [Full Text] [Related]
3. The influence of cytotoxic drugs on the immunophenotype of blast cells in paediatric B precursor acute lymphoblastic leukaemia.
Prelog T; Bucek S; Brozic A; Peterlin J; Kavcic M; Omerzel M; Markelc B; Jesenko T; Prevodnik VK
Radiol Oncol; 2024 Mar; 58(1):133-144. PubMed ID: 38378030
[TBL] [Abstract] [Full Text] [Related]
4. Second-line treatment of diffuse large B-cell lymphoma: Evolution of options.
Fabbri N; Mussetti A; Sureda A
Semin Hematol; 2023 Nov; 60(5):305-312. PubMed ID: 38342663
[TBL] [Abstract] [Full Text] [Related]
5. Histiocytic sarcoma following car T-cell therapy: a case report.
An K; He Y; Tang Y; Gu X; Qian J; Li B
Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
[TBL] [Abstract] [Full Text] [Related]
6. Management of Patients Undergoing car-T Cell Therapy in Germany.
Penack O; Dreger P; Ajib S; Ayuk F; Baermann BN; Bug G; Kriege O; Jentzsch M; Kobbe G; Koenecke C; Lutz M; Martin S; Schlegel PG; Schroers R; von Tresckow B; Vucinic V; Subklewe M; Bethge W; Wolff D
Oncol Res Treat; 2024; 47(3):65-75. PubMed ID: 38198763
[TBL] [Abstract] [Full Text] [Related]
7. Case report: Differential diagnosis of highly amplified anti-CD5 car T cells and relapsed lymphoma cells in a patient with refractory ALK positive anaplastic large cell lymphoma.
Mu W; Zhang M; Hu G; Han Y; Mao X; Chen C; Shen K; Dai Z; Zhu X; Zhou X; Huang L; Ao Q; Xiao M
Front Immunol; 2023; 14():1280007. PubMed ID: 38143760
[TBL] [Abstract] [Full Text] [Related]
8. Is oligometastatic disease an applicable and useful concept in haematologic malignancies? A narrative review of radiation therapy standards, modern techniques, and innovations.
Ollivier L; Debbi K; To NH; Cailleteau A; Supiot S; Mervoyer A; Guimas V; Belkacémi Y
Cancer Radiother; 2024 Feb; 28(1):119-130. PubMed ID: 38143233
[TBL] [Abstract] [Full Text] [Related]
9. Role of FDG PET/CT in Patients With lymphoma Treated With Chimeric Antigen Receptor T-Cell Therapy: Current Concepts.
Murad V; Kohan A; Ortega C; Prica A; Veit-Haibach P; Metser U
AJR Am J Roentgenol; 2024 Mar; 222(3):e2330301. PubMed ID: 38054958
[TBL] [Abstract] [Full Text] [Related]
10. The salvage role of allogeneic hematopoietic stem-cell transplantation in relapsed/refractory diffuse large B cell lymphoma.
Min GJ; Jeon YW; Kim TY; Kwag D; Kim BS; Lee J; Lee JH; Park SS; Park S; Yoon JH; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Kim HJ; Min CK; Lee JW; Cho SG
Sci Rep; 2023 Oct; 13(1):17496. PubMed ID: 37840059
[TBL] [Abstract] [Full Text] [Related]
11. [car-T cells, an innovative therapy].
Saliot M; Murzot L
Rev Infirm; 2023 Oct; 72(294):42-44. PubMed ID: 37838372
[TBL] [Abstract] [Full Text] [Related]
12. Chylothorax after chimeric antigen receptor T cell therapy for relapsed and refractory diffuse large B-cell lymphoma: A case report.
Chen HH; Kuo CY; Ho CL; Chen YC
Medicine (Baltimore); 2023 Oct; 102(41):e35432. PubMed ID: 37832125
[TBL] [Abstract] [Full Text] [Related]
13. Outcome after chimeric antigen receptor (car) T-cell therapy failure in large B-cell lymphomas.
Dodero A; Bramanti S; Di Trani M; Pennisi M; Ljevar S; Chiappella A; Massimo M; Guidetti A; Corrado F; Nierychlewska PM; Di Rocco A; Lorenzini D; Daoud R; De Philippis C; Santoro A; Carlo-Stella C; Corradini P
Br J Haematol; 2024 Jan; 204(1):151-159. PubMed ID: 37690811
[TBL] [Abstract] [Full Text] [Related]
14. Accelerated Chronic Lymphocytic Leukemia and Richter Transformation in the Era of Novel Agents.
Levy Yurkovski I; Tadmor T
Acta Haematol; 2024; 147(1):73-83. PubMed ID: 37666234
[TBL] [Abstract] [Full Text] [Related]
15. Study on primary central nervous system lymphoma in pediatric patients.
Li X; Gong J
Childs Nerv Syst; 2023 Aug; 39(8):2037-2043. PubMed ID: 37401975
[TBL] [Abstract] [Full Text] [Related]
16. Chimeric Antigen Receptor T-Cell Therapy and Imaging Applications for Large B-Cell lymphoma.
Mulholland N; Chandra J; Sanderson R; Kuhnl A
Radiology; 2023 Jun; 307(5):e221362. PubMed ID: 37310248
[TBL] [Abstract] [Full Text] [Related]
17. Richter Transformation of Chronic Lymphocytic Leukemia-Are We Making Progress?
Audil HY; Kosydar SR; Larson DP; Parikh SA
Curr Hematol Malig Rep; 2023 Oct; 18(5):144-157. PubMed ID: 37294394
[TBL] [Abstract] [Full Text] [Related]
18. Real-world evidence of the safety and survival with CD19 car-T cell therapy for relapsed/refractory solid organ transplant-related PTLD.
McKenna M; Epperla N; Ghobadi A; Liu J; Lazaryan A; Ibrahim U; Jacobson CA; Naik SG; Nastoupil L; Chowdhury SM; Voorhees TJ; Jacobs MT; Farooq U; Osman K; Olszewski AJ; Ahmed S; Evens AM
Br J Haematol; 2023 Jul; 202(2):248-255. PubMed ID: 37129856
[TBL] [Abstract] [Full Text] [Related]
19. Infectious complications of chimeric antigen receptor (car) T-cell therapies.
Gea-Banacloche JC
Semin Hematol; 2023 Jan; 60(1):52-58. PubMed ID: 37080711
[TBL] [Abstract] [Full Text] [Related]
20. Severe cytopenia after CD19 car T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party.
Penack O; Peczynski C; Koenecke C; Polge E; Kuhnl A; Fegueux N; Daskalakis M; Kröger N; Dreger P; Besley C; Schanz U; Bloor A; Ganser A; Forcade E; Corral LL; Passweg JR; Novak U; Moiseev I; Schoemans H; Basak GW; Chabannon C; Sureda A; Averbuch D; Glass B; de la Camara R; Peric Z
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072350
[TBL] [Abstract] [Full Text] [Related]
[Next]
